# Kura Oncology, Inc.: filings

KURA · Nasdaq · CIK 1422143 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kura.md) · [Financials](/companies/kura/financials.md) · [Filings](/companies/kura/filings.md) · [Insiders](/companies/kura/insiders.md)

## Reports and events: 238 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 237, 8-K 149, SC 13G/A 59, 10-Q 53, 144 48, 3 30, SC 13G 23, 10-K 18, 424B5 18, 424B3 16, S-8 16, SCHEDULE 13G/A 15, CORRESP 14, DEFA14A 12, CT ORDER 11, DEF 14A 11, EFFECT 9, UPLOAD 8, S-3 6, ARS 4, 5 3, S-1/A 3, SCHEDULE 13G 3, 8-K/A 2, D 2, PRE 14A 2, S-1 2, S-3/A 2, S-3ASR 2, 3/A 1, 424B4 1, 4/A 1, 8-A12B 1, CERTNAS 1, DEF 14C 1, POS AM 1, POS EX 1, PRE 14C 1, S-3MEF 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-09 | 07:05 ET | [8-K](/filings/0001193125-26-385881.md) | 8.01 Other events | 0001193125-26-385881 |
| 2026-09-08 | 07:05 ET | [8-K](/filings/0001193125-26-384363.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-384363 |
| 2026-08-12 | 16:15 ET | [10-Q](/filings/0001193125-26-346884.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346884 |
| 2026-08-12 | 16:10 ET | [8-K](/filings/0001193125-26-346856.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346856 |
| 2026-07-29 | 17:06 ET | [8-K](/filings/0001193125-26-324202.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-324202 |
| 2026-06-04 | 16:05 ET | [8-K](/filings/0001193125-26-257368.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257368 |
| 2026-05-12 | 16:15 ET | [10-Q](/filings/0001193125-26-219481.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219481 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001193125-26-219422.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219422 |
| 2026-04-10 | 16:25 ET | [DEF 14A](/filings/0001193125-26-151335.md) | Proxy statement, period 2026-06-04 | 0001193125-26-151335 |
| 2026-03-05 | 07:31 ET | [10-K](/filings/0001193125-26-092567.md) | Annual report, period 2025-12-31 | 0001193125-26-092567 |
| 2026-03-05 | 06:35 ET | [8-K](/filings/0001193125-26-092465.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092465 |
| 2026-01-29 | 17:25 ET | [8-K](/filings/0001193125-26-029705.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-029705 |
| 2026-01-12 | 06:05 ET | [8-K](/filings/0001193125-26-009649.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009649 |
| 2025-12-02 | 08:10 ET | [8-K](/filings/0001193125-25-304559.md) | 8.01 Other events | 0001193125-25-304559 |
| 2025-11-13 | 16:27 ET | [8-K](/filings/0001193125-25-280255.md) | 8.01 Other events | 0001193125-25-280255 |
| 2025-11-04 | 07:30 ET | [10-Q](/filings/0001193125-25-263589.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263589 |
| 2025-11-04 | 06:35 ET | [8-K](/filings/0001193125-25-263491.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263491 |
| 2025-10-24 | 07:24 ET | [8-K](/filings/0001193125-25-249348.md) | 8.01 Other events | 0001193125-25-249348 |
| 2025-10-16 | 16:11 ET | [8-K](/filings/0001193125-25-241416.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241416 |
| 2025-08-07 | 16:16 ET | [10-Q](/filings/0000950170-25-105051.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105051 |
| 2025-08-07 | 16:10 ET | [8-K](/filings/0000950170-25-105024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105024 |
| 2025-07-01 | 06:09 ET | [8-K](/filings/0001193125-25-153393.md) | 1.01 Entry into a material agreement | 0001193125-25-153393 |
| 2025-06-18 | 17:20 ET | [8-K](/filings/0001193125-25-142816.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-142816 |
| 2025-06-06 | 16:05 ET | [8-K](/filings/0000950170-25-083046.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-083046 |
| 2025-06-03 | 06:04 ET | [8-K](/filings/0001193125-25-133717.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-133717 |
| 2025-05-01 | 16:15 ET | [10-Q](/filings/0000950170-25-061848.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061848 |
| 2025-05-01 | 16:10 ET | [8-K](/filings/0000950170-25-061836.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-061836 |
| 2025-04-11 | 16:50 ET | [DEF 14A](/filings/0000950170-25-053335.md) | Proxy statement, period 2025-06-05 | 0000950170-25-053335 |
| 2025-02-28 | 16:01 ET | [10-K](/filings/0000950170-25-029975.md) | Annual report, period 2024-12-31 | 0000950170-25-029975 |
| 2025-02-26 | 16:05 ET | [8-K](/filings/0000950170-25-027706.md) | 2.02 Results of operations | 0000950170-25-027706 |
| 2025-02-05 | 16:13 ET | [8-K](/filings/0001193125-25-020831.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-020831 |
| 2025-01-14 | 16:36 ET | [8-K](/filings/0001193125-25-006197.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-006197 |
| 2025-01-06 | 16:35 ET | [8-K](/filings/0001193125-25-002189.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-25-002189 |
| 2024-12-20 | 16:07 ET | [8-K](/filings/0001193125-24-283109.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-283109 |
| 2024-11-20 | 17:21 ET | [8-K](/filings/0001193125-24-262641.md) | 1.01 Entry into a material agreement | 0001193125-24-262641 |
| 2024-11-07 | 16:15 ET | [10-Q](/filings/0000950170-24-123363.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123363 |
| 2024-11-07 | 16:10 ET | [8-K](/filings/0000950170-24-123321.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123321 |
| 2024-09-17 | 16:05 ET | [8-K](/filings/0001193125-24-220529.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-220529 |
| 2024-08-08 | 16:15 ET | [10-Q](/filings/0000950170-24-093997.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093997 |
| 2024-08-08 | 16:10 ET | [8-K](/filings/0000950170-24-093945.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093945 |
| 2024-06-07 | 16:05 ET | [8-K](/filings/0000950170-24-070584.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070584 |
| 2024-05-24 | 16:06 ET | [8-K](/filings/0001193125-24-147030.md) | 8.01 Other events | 0001193125-24-147030 |
| 2024-05-02 | 16:15 ET | [10-Q](/filings/0000950170-24-052136.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052136 |
| 2024-05-02 | 16:10 ET | [8-K](/filings/0000950170-24-052109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052109 |
| 2024-04-12 | 16:26 ET | [DEF 14A](/filings/0000950170-24-044066.md) | Proxy statement, period 2024-04-12 | 0000950170-24-044066 |
| 2024-02-27 | 16:05 ET | [10-K](/filings/0000950170-24-021094.md) | Annual report, period 2023-12-31 | 0000950170-24-021094 |
| 2024-02-27 | 16:03 ET | [8-K](/filings/0000950170-24-021087.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021087 |
| 2024-01-30 | 07:08 ET | [8-K](/filings/0001193125-24-018713.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-018713 |
| 2024-01-26 | 16:08 ET | [8-K](/filings/0001193125-24-016715.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-016715 |
| 2023-12-22 | 09:01 ET | [8-K](/filings/0001193125-23-301830.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-301830 |

Page 1 of 5. [Older](/companies/kura/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.